Radioimmunoassay for nicotine and cotinine. 1993

H Van Vunakis, and H B Gijka, and J J Langone

UI MeSH Term Description Entries
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002138 Calibration Determination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output. Calibrations
D003367 Cotinine The N-glucuronide conjugate of cotinine is a major urinary metabolite of NICOTINE. It thus serves as a biomarker of exposure to tobacco SMOKING. It has CNS stimulating properties. Scotine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

H Van Vunakis, and H B Gijka, and J J Langone
January 1987, IARC scientific publications,
H Van Vunakis, and H B Gijka, and J J Langone
January 1982, Methods in enzymology,
H Van Vunakis, and H B Gijka, and J J Langone
January 1982, Methods in enzymology,
H Van Vunakis, and H B Gijka, and J J Langone
June 1985, Clinical chemistry,
H Van Vunakis, and H B Gijka, and J J Langone
November 1973, Biochemistry,
H Van Vunakis, and H B Gijka, and J J Langone
January 1990, Drug metabolism and disposition: the biological fate of chemicals,
H Van Vunakis, and H B Gijka, and J J Langone
September 1993, International journal of clinical pharmacology, therapy, and toxicology,
H Van Vunakis, and H B Gijka, and J J Langone
October 1977, Biochemical pharmacology,
H Van Vunakis, and H B Gijka, and J J Langone
February 1994, Pathologie-biologie,
H Van Vunakis, and H B Gijka, and J J Langone
July 1993, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!